CW

Christoph Waer

Europe, Vlaams-Brabant, Belgium, Leuven

Description

Christoph Waer joined Korys in 2012 as investment analyst to support the three investment lines. Prior to that, he was active as a Junior An...

Investor Profile

Christoph Waer has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in Belgium.
  • Strong thematic focus on Biotechnology, Clinical Trials, Manufacturing.

Stage Focus

  • Series B (100%)

Country Focus

  • Belgium (100%)

Industry Focus

  • Biotechnology
  • Clinical Trials
  • Manufacturing
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Christoph Waer frequently co-invest with?

BNP Paribas Fortis
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
Gemma Frisius Fund
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
Korys
Europe, Vlaams-Brabant, Belgium, Halle
Co-Investments: 1
KU Leuven
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
PMV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1

Which angels does Christoph Waer often collaborate with?

BM
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1

What are some of recent deals done by Christoph Waer?

reMYND

Leuven, Vlaams-Brabant, Belgium

reMYND drives the development of disease-modifying treatments against protein misfolding disorders.

BiotechnologyClinical TrialsManufacturingMedical
Series BDec 18, 2018
Amount Raised: $13,651,023